YFY Inc: Segment Analysis

YFY Inc (YFY) is a paper and packaging company, with an operation of pulp and fine paper manufacturing, containerboard and packaging, consumer tissue products, and related investment, technology, and service businesses.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

YFY continued to position R&D as a cross-segment capability supporting product differentiation in paper, packaging, and consumer products. The company selectively advanced higher-value materials and digital, technology adjacencies through subsidiaries. R&D activities focused on papermaking, pulp, and forestry-related development, containerboard and packaging, household and consumer tissue product enhancement, and specialty materials and technology adjacencies. The R&D activities of the company include papermaking, pulp, and forestry-related development; it focuses on fiber utilization, yield improvement, energy and chemical optimization, and quality stability. Containerboard, corrugated, and functional packaging; emphasizes lightweighting, performance under humidity/compression, and converting efficiency. Household and consumer tissue product enhancement; supports formulation and process tuning, SKU upgrades, and production efficiency. Specialty materials and technology adjacencies; involves continuous product and application development, qualification with customers, and performance testing. In FY2024, the company incurred expenses of TWD615.4 million on R&D, which as a percentage of revenue, stood at 0.8%.